Innoviva (INVA) EBIAT: 2009-2025
Historic EBIAT for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $89.9 million.
- Innoviva's EBIAT rose 7312.04% to $89.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.6 million, marking a year-over-year increase of 752.96%. This contributed to the annual value of $23.4 million for FY2024, which is 86.98% down from last year.
- As of Q3 2025, Innoviva's EBIAT stood at $89.9 million, which was up 41.17% from $63.7 million recorded in Q2 2025.
- Over the past 5 years, Innoviva's EBIAT peaked at $229.3 million during Q3 2022, and registered a low of -$46.6 million during Q1 2025.
- Moreover, its 3-year median value for EBIAT was $2.6 million (2024), whereas its average is $19.2 million.
- As far as peak fluctuations go, Innoviva's EBIAT tumbled by 2,809.77% in 2024, and later skyrocketed by 7,312.04% in 2025.
- Innoviva's EBIAT (Quarterly) stood at -$6.0 million in 2021, then slumped by 70.56% to -$10.3 million in 2022, then crashed by 92.43% to -$19.8 million in 2023, then skyrocketed by 113.10% to $2.6 million in 2024, then spiked by 7,312.04% to $89.9 million in 2025.
- Its EBIAT stands at $89.9 million for Q3 2025, versus $63.7 million for Q2 2025 and -$46.6 million for Q1 2025.